Sun Pharma Advanced Research Company, 532872, SPARC Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,851.33
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8,636.65
N/A
26.69

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.64
5.48
-1.90

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
7.19
9.66

PAT CAGR (%)

10 Years
5 Years
3 Years

-
8.88
13.77

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

-14.05
-14.05
-14.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-36.15
-29.98
-34.26

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 21.18 31.54 -32.85% 23.95 28.46 -15.85% 47.69 25.24 88.95% 131.09 62.15 110.93%
Expenses 112.65 94.14 19.66% 126.13 106.66 18.25% 137.26 91.78 49.55% 114.91 73.42 56.51%
EBITDA -91.47 -62.60 - -102.18 -78.20 - -89.57 -66.54 - 16.18 -11.27 -
EBIDTM -431.87% -198.48% -426.64% -274.77% -187.82% -263.63% 12.34% -18.13%
Other Income 8.49 0.06 14,050.00% 10.19 0.18 5,561.11% 10.73 0.22 4,777.27% 0.03 0.34 -91.18%
Interest 0.26 2.86 -90.91% 0.26 1.63 -84.05% 0.21 2.22 -90.54% 2.93 2.33 25.75%
Depreciation 3.18 3.00 6.00% 3.10 2.70 14.81% 2.94 2.51 17.13% 3.13 2.58 21.32%
PBT -86.42 -68.40 - -95.35 -82.35 - -81.99 -71.05 - 10.15 -15.84 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -86.42 -68.40 - -95.35 -82.35 - -81.99 -71.05 - 10.15 -15.84 -
PATM -408.03% -216.87% -398.12% -289.35% -171.92% -281.50% 7.74% -25.49%
EPS -2.66 -2.11 - -2.94 -2.54 - -2.53 -2.19 - 0.31 -0.49 -

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 21.18 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 112.65 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA -91.47 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM -431.87% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 8.49 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.26 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 3.18 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT -86.42 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -86.42 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM -408.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS -2.66 0.00 - 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 223.91 238.78 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 167.03 Net Sales Growth 51.92% 73.97% -45.74% 229.33% -58.00% 133.67% -56.77% 12.24% 3.56% -6.76% Cost Of Goods Sold 22.47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 201.44 238.78 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 167.03 GP Margin 89.96% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 490.95 452.84 324.00 387.93 386.83 334.16 320.87 303.72 224.48 190.83 133.54 Power & Fuel Cost - 5.75 4.62 4.60 5.14 5.08 4.92 4.67 4.49 4.78 3.95 % Of Sales - 2.41% 3.37% 1.82% 6.69% 2.78% 6.29% 2.58% 2.78% 3.07% 2.36% Employee Cost - 107.00 98.31 91.59 93.09 81.06 100.92 84.30 56.60 45.79 40.40 % Of Sales - 44.81% 71.63% 36.21% 121.20% 44.33% 128.95% 46.57% 35.09% 29.40% 24.19% Manufacturing Exp. - 180.31 134.27 209.78 30.47 17.81 31.79 29.39 26.42 17.96 16.19 % Of Sales - 75.51% 97.83% 82.93% 39.67% 9.74% 40.62% 16.24% 16.38% 11.53% 9.69% General & Admin Exp. - 154.10 84.39 78.49 251.32 221.40 181.18 180.29 131.88 119.37 71.71 % Of Sales - 64.54% 61.49% 31.03% 327.20% 121.07% 231.51% 99.60% 81.77% 76.65% 42.93% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 5.68 2.41 3.48 6.81 8.80 2.05 5.06 5.08 2.94 0.00 % Of Sales - 2.38% 1.76% 1.38% 8.87% 4.81% 2.62% 2.80% 3.15% 1.89% 0.77% EBITDA -267.04 -214.06 -186.75 -134.97 -310.02 -151.29 -242.61 -122.70 -63.20 -35.09 33.49 EBITDA Margin -119.26% -89.65% -136.07% -53.36% -403.62% -82.73% -310.01% -67.78% -39.19% -22.53% 20.05% Other Income 29.44 10.88 6.84 5.41 9.76 13.51 4.94 13.72 2.94 3.03 10.00 Interest 3.66 7.63 13.33 10.65 2.67 0.09 0.12 1.82 2.16 0.22 5.60 Depreciation 12.35 11.77 10.16 10.92 9.48 7.55 8.18 8.24 7.58 7.24 3.57 PBT -253.61 -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.66% PAT -253.61 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 PAT before Minority Interest -253.61 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -113.26% -93.22% -148.20% -59.75% -406.72% -79.53% -251.73% -65.76% -43.40% -25.38% 18.15% PAT Growth 0.00% - - - - - - - - - EPS -7.82 -6.86 -6.27 -4.66 -9.63 -4.48 -6.07 -3.67 -2.16 -1.22 0.93

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 512.78 31.23 -168.25 -18.64 296.24 184.72 158.16 31.80 99.80 139.30 Share Capital 32.45 27.19 26.21 26.21 26.21 25.09 24.69 23.67 23.67 23.67 Total Reserves 480.32 -230.22 -194.46 -44.84 270.03 67.96 133.47 6.23 76.13 115.63 Non-Current Liabilities 138.41 77.43 164.59 55.85 7.20 11.98 10.36 10.02 9.72 9.45 Secured Loans 0.00 0.00 112.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 6.38 1.09 1.64 2.18 2.73 3.27 3.82 Long Term Provisions 8.14 8.15 8.63 10.23 6.11 10.34 8.18 7.30 6.37 5.48 Current Liabilities 178.95 171.43 233.35 235.36 95.04 116.11 108.03 124.84 37.15 38.79 Trade Payables 148.25 72.19 91.17 158.84 82.92 102.48 94.45 58.15 27.01 29.75 Other Current Liabilities 24.15 93.96 56.44 11.20 7.66 9.42 9.81 12.09 8.98 7.58 Short Term Borrowings 0.05 0.00 80.00 60.00 0.00 0.10 0.41 52.48 0.40 0.82 Short Term Provisions 6.49 5.28 5.75 5.31 4.46 4.10 3.35 2.12 0.77 0.64 Total Liabilities 830.14 280.09 229.69 272.57 398.48 312.81 276.55 166.66 146.67 187.54 Net Block 105.75 91.87 90.56 103.86 57.56 51.74 69.16 69.96 66.79 64.49 Gross Block 146.22 133.15 122.51 135.50 80.22 67.17 77.28 106.82 96.38 86.98 Accumulated Depreciation 40.47 41.28 31.95 31.64 22.66 15.44 8.12 36.86 29.58 22.49 Non Current Assets 375.16 208.93 166.58 205.38 141.09 137.59 118.27 98.88 83.46 76.87 Capital Work in Progress 27.00 26.37 5.23 32.07 24.13 3.27 1.47 0.87 0.02 0.76 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 64.80 67.83 70.64 69.24 59.29 82.48 47.45 27.99 16.55 11.50 Other Non Current Assets 177.61 22.87 0.15 0.20 0.12 0.10 0.19 0.07 0.09 0.11 Current Assets 454.96 71.15 63.11 67.19 257.38 175.22 158.28 66.59 62.93 110.12 Current Investments 290.90 11.66 6.43 8.49 210.58 107.57 9.65 0.00 0.00 6.50 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 32.71 27.74 17.58 16.05 10.17 17.56 38.90 9.16 19.89 28.00 Cash & Bank 111.58 1.23 9.31 0.46 0.68 1.32 70.31 12.75 17.34 6.56 Other Current Assets 19.78 2.50 8.10 2.86 35.96 48.77 39.43 44.69 25.70 69.06 Short Term Loans & Adv. 15.80 28.02 21.70 39.33 33.39 46.73 37.48 43.35 24.27 63.34 Net Current Assets 276.02 -100.28 -170.24 -168.17 162.34 59.11 50.25 -58.24 25.79 71.33 Total Assets 830.12 280.08 229.69 272.57 398.47 312.81 276.55 166.65 146.67 187.55

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -69.12 -208.23 -151.90 -210.81 -171.91 -182.77 -128.04 -44.21 -41.17 36.90 PBT -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 Adjustment 6.99 16.67 48.75 9.44 -21.77 3.82 -1.14 9.25 4.73 0.90 Changes in Working Capital 141.11 -26.05 -47.88 102.02 -0.17 20.48 12.86 30.41 -3.74 9.80 Cash after chg. in Working capital -74.48 -212.78 -150.26 -200.95 -167.38 -221.68 -107.32 -30.34 -38.53 45.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 5.37 4.54 -1.63 -9.86 -4.54 -10.08 -20.72 -13.87 -2.64 -8.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 48.98 0.00 0.00 0.00 0.00 Cash From Investing Activity -548.28 -29.17 1.56 155.35 -102.19 -104.62 -6.61 -13.08 53.00 43.59 Net Fixed Assets -13.70 -31.78 39.83 -63.22 -33.91 8.31 28.94 -11.29 -8.66 -3.01 Net Investments -279.24 -5.23 2.06 202.09 -103.01 -97.92 -9.65 0.00 6.50 90.41 Others -255.34 7.84 -40.33 16.48 34.73 -15.01 -25.90 -1.79 55.16 -43.81 Cash from Financing Activity 616.76 229.32 159.28 55.46 274.25 224.01 194.25 50.55 -1.26 -80.84 Net Cash Inflow / Outflow -0.64 -8.08 8.95 0.00 0.15 -63.38 59.60 -6.74 10.57 -0.35 Opening Cash & Equivalents 1.22 9.30 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33 Closing Cash & Equivalent 0.58 1.22 9.30 0.35 0.35 0.20 63.58 4.00 10.63 0.01

Financial Ratios

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 15.80 -7.47 -6.42 -0.71 11.30 3.71 6.41 1.21 4.18 5.82 ROA -40.10% -79.80% -60.18% -93.11% -40.89% -66.85% -53.72% -44.68% -23.65% 15.29% ROE -143.72% 0.00% 0.00% -225.08% -74.72% -156.84% -127.40% -109.16% -33.17% 24.62% ROCE -69.44% -225.57% -254.10% -178.95% -59.95% -113.05% -94.66% -71.37% -31.74% 24.02% Fixed Asset Turnover 1.71 1.07 1.96 0.71 2.48 1.08 1.97 1.59 1.70 1.95 Receivable days 46.20 60.25 24.26 62.28 27.67 131.66 48.45 32.87 56.11 57.97 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 316.55 300.15 244.72 218.01 163.03 136.14 120.80 Cash Conversion Cycle 46.20 60.25 24.26 -254.27 -272.48 -113.05 -169.56 -130.16 -80.03 -62.83 Total Debt/Equity 0.00 -0.37 -1.37 -3.59 0.01 0.02 0.02 1.94 0.04 0.04 Interest Cover -28.15 -14.26 -13.19 -115.79 -1547.78 -1596.71 -64.41 -31.45 -180.04 7.13

Top Investors:

sun pharmaceutical industries key employees benefit trust

jhunjhunwala rekha rakesh

lakshdeep investments & finance (p) ltd.

vijay mohanlal parekh

paresh mohanlal parekh

enam securities private limited

Annual Reports:

News Update:

Sun Pharma Adv. Res - Quarterly Results
6th Nov 2023, 15:22 PM

Read More
SPARC enters into agreement for SCD-153 with JHU and IOCB
2nd Nov 2023, 09:52 AM

SPARC had evaluated SCD-153 under a MTA after which it entered into an Option to License Agreement with the licensors
Read More
SPARC incorporates wholly owned subsidiary in Delaware
26th Sep 2023, 14:05 PM

The main object of the Company is to obtain the services of the WOS which would engage a team of seasoned professionals based in US
Read More

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532872 | NSE: SPARC

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532872 | NSE: SPARC

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: